Ufp Technologies (UFPT) Net Cash Flow Growth (1y) (2011 - 2026)
Ufp Technologies (UFPT) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 76.43% |
| 10 | Ufp Technologies | 1.90 Bn | 1.88 Bn | 44.36 Mn | -134.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -134.92% |
| Dec 31, 2025 | 196.42% |
| Sep 30, 2025 | 642.02% |
| Jun 30, 2025 | -88.88% |
| Mar 31, 2025 | -95.25% |
| Dec 31, 2024 | -67.59% |
| Sep 30, 2024 | -147.28% |
| Jun 30, 2024 | 537.51% |
| Mar 31, 2024 | 193.10% |
| Dec 31, 2023 | 77.60% |
| Sep 30, 2023 | -72.17% |
| Jun 30, 2023 | -160.99% |
| Mar 31, 2023 | 128.20% |
| Dec 31, 2022 | 73.61% |
| Sep 30, 2022 | 57.07% |
| Jun 30, 2022 | -58.84% |
| Mar 31, 2022 | -756.69% |
| Dec 31, 2021 | -423.24% |
| Sep 30, 2021 | -45.42% |
| Jun 30, 2021 | -0.73% |